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Abstract 
In this study, we identified indicators of the state of personalized pharmaceutical care for target population groups at the 
regional level, in a model region, with the aim to develop a differentiated approach to such care. The rationale for the 
choice of Moscow Region as a model region is based on its specific socioeconomic indicators and a comparison of these 
with respective average Russian values. A need was shown to modernize patient-oriented pharmaceutical care, especially 
for certain population groups, such as children, women of working age (mothers), and the elderly. Content analysis of the 
legislation and regulatory documents applicable to public health care at the Federal and regional levels allowed to 
demonstrate their shortcomings in relation to the organization of drug supply for target population groups. A situation 
analysis of the state of drug supply for Moscow Region outpatients and inpatients revealed a room for improvement. 
Analysis and synthesis of data obtained after the application of statistical tests allowed structuring of indicators that will be 
used in the development of key elements of a conceptual model of rational drug supply within the framework of 
personalized health care for the population groups requiring a differentiated approach the most (i.e., target groups). 
Keywords: Personalized Health Care, Patient-Oriented Pharmaceutical Care, Regional Drug Supply Systems, Medico-
Social Indicators, Conceptual Modeling, Target Population Groups. 
 
Introduction 
Personalized medicine is a relatively new field 
emerging at the current stage of public health care 
development. The development of personalized 
medicinal products is known to require a long time 
and considerable resources. A personified approach to 
treatment means that a rather large number of 
hereditary and acquired factors have to be taken into 
consideration in each individual case, and the health 
status of patients in different age groups is of great 
importance [1, 23]. 
The top national priorities of the Russian 
Federation, which largely determine the country’s 
future and its socioeconomic development and 
security, include safe and protected childhood; 
protection of the health of women of reproductive 
potential; and prolongation of the active period of life 
while improving its quality [2-4]. Timely detection of 
diseases, prophylaxis, diagnosis, treatment, and 
rehabilitation in each region of the Russian Federation 
also have special medical and socioeconomic 
importance [5-8, 24]. The situation requires active use 
of the opportunities of personalized medicine, which 
allows more accurate prediction of the risks of certain 
disorders, prophylactic measures, and selection of 
rational pharmacological therapy. Many regional 
health care authorities are actively involved in the 
development and implementation of a medico-social 
concept focusing on improvement of the quality of 
life in all age groups of the general population. 
Guidelines based on results of research studies can 
significantly contribute to boosting the efficacy of 
undertaken measures and making them less time-
consuming. From this standpoint, development and 
implementation of a methodological basis for a 
differentiated approach to providing pharmaceutical 
care at the regional level to children, women of 
reproductive age, including pregnant and 
breastfeeding women, as well as the elderly, appear to 
be of scientific and practical interest. 
Study goal: to identify drug supply availability 
indicators in target population groups through analysis 
of the current legislation and an experimental study in 
order to develop a differentiated approach to 
providing pharmaceutical care at the regional level. 
The following objectives had to be met to 
achieve the study goal: 
1) To justify the choice of Moscow Region as a 
model region in this study; 
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2) To analyze the characteristic features of the 
model region; 
3) To study the legislation and regulatory 
documents applicable to public health care and 
drug supply in different age groups of the Russian 
population; 
4) To perform a situation analysis of the state of 
drug supply for outpatients and inpatients in the 
model region; 
5) To find resources for the implementation of a 
differentiated approach to the provision of 
pharmaceutical care in target population groups 
using the obtained list of care availability 
indicators. 
Materials and Methods 
The study methods were based on the cornerstones 
of the current management theory, the fundamentals 
of the legal regulation of health care and the 
circulation of medicinal products, the principles of 
personalized medicine, and the publications of leading 
researchers in pharmaceutical management. 
Source data included legislative and regulatory 
documents of the Russian Federation, Central Federal 
District (CFD), and Moscow Region; information 
from the regional State Statistical Service 
(Mosoblstat), data reported by the Federal Service for 
Surveillance in Healthcare, materials of sociological 
studies and experimental data. 
The study objects were medical and 
pharmaceutical organizations of Moscow Region, 
pharmaceutical and health care professionals 
employed by them; legislative and regulatory 
documents in the field of Russian health care and the 
public drug supply system (twenty regulatory 
documents published from 1994 to 2017); Rosstat 
(Federal State Statistics Service) materials; regional 
demographic and morbidity statistics; data on staff 
with medical and pharmaceutical education employed 
by health care and pharmaceutical organizations, on 
the structure of budget spending and the MMI 
(Mandatory Medical Insurance) budget allocated to 
drug supply (for 2010-2018); reports of the Ministry 
of Health of Moscow Region (for 2010-2017); and 
data copied from reports of the aforementioned 
organizations. 
Economic-statistical, sociological, and graphical 
research methods were employed in the study; 
systemic, situational, historic, retrospective, and 
content analyses were carried out. 
Results and Discussion 
In accordance with the employed study algorithm, 
at the first stage we detected and analyzed the 
characteristic features of Moscow Region in order to 
justify its choice as a model region. Analysis of data 
obtained from the state statistical bodies, regional 
demographic and morbidity statistics; reports of the 
Ministry of Health of Moscow Region and data 
copied from reports of the aforementioned 
organizations produced the following geographical, 
demographic, and medico-social characteristics of the 
model region. 
Moscow Region has a characteristic geographical 
location, being one of the largest Russian Federation 
Subjects included in the CFD; it borders seven other 
Russian regions and a city of federal importance, 
Moscow.  
The area of the Region is 44,329 km², with a mean 
population density of 167.46 people/km², makes it the 
largest Russian region (with the exception of the cities 
of Moscow and Saint Petersburg), which is due to a 
high proportion of town population. The districts 
closest to Moscow (Lyuberetsky, Balashikhinsky, 
Krasnogorsky, and some others) have the highest 
population density. The total population is 7,508,764 
people, as of 1 January 2018.  
The overall structure of the Region’s population is 
presented in table 1. Moscow Region has no capital 
city. It consists of 29 districts and 39 town districts 
[9]. 
A specific feature of the model region is a 
significant scale of workforce commuting (Table 2) 
[9-11, 25]. A significant proportion of the Region’s 
economically active population find a job and obtain 
medical and pharmaceutical care in Moscow. 
Therefore, drug supply in the Region is provided to 
the “constant”, non-commuting part of the population 
(mainly children and the elderly). 
Moscow’s location and the availability of federal 
clinics both in Moscow and in the Region that have 
always been accessible mean that health centres have 
developed predominantly at the local and district 
levels, including central district hospitals. The main 
types of specialized care are provided in Moscow, 
because Moscow Region lacks its own inpatient 
facilities, having none in rheumatology or 
immunology. 
As the data included in Tables 1 and 2 show, the 
demographic structure of the model region’s 
population is characterized by a predominance of 
town population, women, and people of working age; 
the Region has the highest migration flows within 
Russia’s CFD. 
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Table-1: The demographic structure of Moscow Region’s population 
Year Demographics: population  
Urban 
% 
Rural 
% 
Male 
% 
Female 
% 
Youngerthan working 
age, % 
Workingage, % Older than 
working 
age, % 
2018 81.7 18.3 46.2 53.8 17.5 57.6 24.9 
Table-2: Comparison of Russian Federation Subjects in the CFD by the proportion of population moving to 
work in other Regions 
Central Federal 
District 
Proportion of people leaving, 
% 
Central Federal 
District 
Proportion of people leaving, 
% 
Belgorod Region 4.1 Moscow 21.8 
Bryansk Region 3.9 Oryol Region 2.0 
Vladimir Region 3.4 Ryazan Region 3.3 
Voronezh Region 6.6 Smolensk Region 3.6 
Ivanovo Region 3.0 Tambov Region 4.0 
Kaluga Region 3.3 Tver Region 4.1 
Kostroma Region 2.7 Tula Region 4.0 
Kursk Region 3.4 Yaroslavl Region 3.5 
Lipetsk Region 3.5 Moscow 19.8 
  Total 100 
 
The medico-social specifics of the Region are 
also reflected by the indicators presented in Table 3. 
Table-3: Individual medico-social indicators of the model region 
No. Indicator, 2017 MoscowRegion Russian Federation 
1 Infant mortality (per 1000 live births) 4.1 5.2 
2 Birth rate (per 1000 population) 12.0 11.5 
3 All-cause mortality rate (per 1000 population) 12.4 12.4 
5 Maternal mortality ratio (per 100,000 live births) 5.4 7.3 
 
The pharmaceutical care availability level can be 
assessed using various criteria, including the 
infrastructure of the pharmaceutical market. In the 
reported study, the pharmaceutical care availability 
level was assessed by an organizational criterion, i.e., 
availability of pharmacies preparing drugs. To do this, 
we selected pharmacies preparing drugs using data 
from the Unified License Registry of the Federal 
Service for Surveillance in Health Care 
(Roszdravnadzor) [12]. 
The extremely low number of drug-producing 
pharmacies has a negative effect on the introduction 
of a personalized approach to drug supply for target 
population groups, because a physician is unable to 
select the drug composition and strength on an 
individual basis, taking into consideration the patient's 
age, weight, and comorbidities; the intervals between 
drug prescription, production, and use cannot be 
reduced; the use of preservatives cannot be avoided 
since the formulation has to be stable [13-15]. 
Since Moscow Region’s population is dominated 
by women, primarily of childbearing age, 
organization of drug supply in this population requires 
special attention. The limited scope of drugs approved 
for use during pregnancy and of required dosage 
forms precludes full-scale drug supply for these 
patients. For instance, thyroid diseases affect female 
health with regard to the conception potential, the 
course of pregnancy, threatening miscarriage, etc. A 
personalized approach to pharmaceutical care in this 
population will allow to avoid the risks and preclude 
undesirable outcomes [16,17]. 
A content analysis of the legislation and regulatory 
documents applicable to public health care at the 
Federal and regional levels was carried out at the next 
stage of the study in accordance with the employed 
algorithm. For this purpose, we selected, analyzed, 
and structured, according to a number of criteria, the 
documents that define the procedure of providing 
medical, pharmaceutical, social care and drug supply 
for the target population groups (Table 4). 
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Table-4: The structure of the legislative and regulatory documents applicable to the organization of drug 
supply for children, women of working age (mothers), elderly people. 
 Children’s health protection Maternal health 
protection 
Elderly 
people’s health 
protection 
Legislative or 
regulatory 
document 
Constitution of the Russian Federation 
Federal Law No. 124-ФЗ “On the basic guarantees of children’s 
rights in the Russian Federation” dated 24 July 1998 
  
Federal Law No. 323-ФЗ "On the fundamentals of public health care in the Russian Federation” dated 
21 November 2011 
Order No. 366н of the Ministry of Health and Social 
Development of the Russian Federation “On approval of the 
procedure of providing paediatric care” dated 16 April 2012 
  
Order No. 328 “On approval of the procedure of providing the social services to individual population 
groups” dated 29 December 2004 
Decree No. 890 of the Government of the Russian Federation “On the state support of the 
development of medical industry and improvement of the supply of drugs and medical devices to the 
population and health centres” dated 30 July 1994 
Federal Law No. 256 “On additional measures of state support for families with 
children” dated 29 December 2006 
 
Federal Law No. 418 “On monthly payments for families with children” dated 28 
December 2017 
 
“Plan of measures to implement the basic provisions of the State Youth Policy of the 
Russian Federation until 2025” approved by Order No. 2403-Р of the Government 
of the Russian Federation dated 29 November 2014 
 
Decree No. 1351 of the President of the Russian Federation “On approval of the 
concept of the demographic policy of the Russian Federation until 2025” 
 
Federal Law No. 178-ФЗ “On state social assistance” dated 17 July 1999 
Decree No. 663/38 of the Government of Moscow Region “On approval of the State Programme of 
Moscow Region ‘Podmoskovye Healthcare’ for the period 2014-2020” dated 23 August 2013 (version 
dated 29 November 2017) 
Decree No. 1640 of the Government of the Russian Federation “On approval of the State Programme 
of the Russian Federation ‘Healthcare Development’” dated 26 December 2017 
 
These data show that children, mothers, and 
families, as well as the elderly, are protected by the 
state. It should be mentioned at the same time that the 
number of regulatory documents in this field is small 
(about 13). We identified the following issues: an 
extremely low proportion of regional legislative 
documents regulating the drug supply procedure (only 
one legislative document), as compared with the 
Federal level. There are no legislative documents 
regulating the process of drug supply for elderly 
patients, with the exception of patients suffering from 
socially important diseases and entitled to receive 
drugs free of charge. 
A situation analysis of the state of drug supply for 
Moscow Region outpatients and inpatients was 
performed from the personalized approach perspective 
at the next stage of the study in accordance with the 
employed algorithm. 
It has been demonstrated that optimization of the 
available range of products is particularly important 
for outpatients. Moscow Region has a rather large 
number of network pharmacies whose stock lists are 
approved by their central offices, which has a negative 
impact on the availability of drugs needed to treat rare 
diseases. At the same time, the feasibility of a patient-
oriented approach in pharmaceutical care has been 
increased by the opportunities that have arisen in 
recent years with drug pre-orders and subsequent 
purchases following delivery to the consumer’s 
pharmacy of choice. 
The study revealed that there are no guidelines for 
pharmacy employees with regard to pharmaceutical 
care for the target population groups, which would be 
indispensable and extremely valuable for the 
pharmaceutical advice that patients receive from 
pharmacy employees. 
The situation analysis of the drug supply for 
inpatients revealed a low proportion of pharmacy-
prepared formulations, which counteracts with the 
implementation of a personalized approach to medical 
and pharmaceutical care. 
Afterwards, we analyzed the range of products 
available for paediatric and elderly patients [18, 19]. It 
was revealed that the Russian National Paediatric 
Formulary includes 517 INNs or 3133 ТNs (without 
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division by pharmaceutical form, formulation, or 
presentation), and 140 of these drugs are not 
manufactured in the Russian Federation (27.1%), 
while the State Drug Registry contains no dosage 
forms for elderly patients at all [20-22]. 
Summarizing results obtained at all stages of the 
study, we were able to compile a list of major 
indicators showing the level of patient-oriented 
pharmaceutical care at the regional level: 
1. Low proportion of drugs for children 
registered in the Russian Federation. 
2. Absence of drugs to be used exclusively by 
elderly patients. 
3. Insufficient amount of drug names approved 
for use during pregnancy. 
4. Extremely small number of guidelines for 
pharmaceutical care in pregnant women, children, 
and the elderly. 
5. Narrow range of drugs available in 
pharmacies for treatment of rare diseases and lack 
of interest of pharmacy personnel in individual 
drug ordering. 
6. Poor development of the network of health 
centres specializing in providing care to the target 
population groups. 
7. Absence of legislative and regulatory 
documents defining the contents and principles of 
personalized pharmaceutical care. 
8. Decreasing number of pharmacies preparing 
medicinal products for human use. 
The presented indicator list demonstrates the 
additional resources of patient-oriented 
pharmaceutical care for the target population groups 
and forms the basis for developing a Concept of this 
type of care at the regional level. Focusing attention 
on personalized care in the target population groups 
can help improve adherence to prevention and 
treatment, thus having a significant effect on the 
quality of life of people living in the respective 
Region. 
In conclusion, the study of a model region 
provided medico-social rationale for adaptation of 
regional drug supply systems to personalized medical 
and pharmaceutical care for certain population groups, 
such as children, women of working age (mothers), 
and the elderly. 
Conclusion 
1. As part of the reported study, the choice of 
Moscow Region as a model region was justified 
based on the geographical, medico-social, 
demographic, organizational, institutional specifics 
and the current All-Russian trends reflected by the 
Region. 
2. The current issues in Moscow Region’s drug 
supply system were characterized; drug supply 
availability indicators in target population groups 
were identified in order to develop a differentiated 
approach to providing pharmaceutical care at the 
regional level. 
3. The study revealed some outpatient and 
inpatient drug supply problems that require a 
solution from personalized pharmaceutical care, 
including a return to pharmacy formulation and 
broadening the range of dosage forms available for 
pregnant women, children, elderly patients, as well 
as preparation of essential guidelines to allow 
appropriate counseling for drug consumers. 
4. The proposed indicator list demonstrates the 
additional resources of patient-oriented 
pharmaceutical care for the target population 
groups, and will form the basis for preparing a 
Concept of development of this type of care at the 
regional level. 
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